EGFR and prostate carcinoma: We identified “Prostate Cancer”, “MTOR signaling pathway”, “RIG-I-like receptor signaling pathway”, “ERBB signaling pathway”, “JAK-STAT signaling pathway” and “Apoptosis” as the potential functional enriched pathways modulated by LRRK2 (Table 3 and Fig. 6).